Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men
1 ARC Epidemiology Unit, The University of Manchester, United Kingdom
2 Department of Endocrinology, The University of Manchester, United Kingdom
3 Clinical Gerontology, The University of Manchester, United Kingdom
4 Institute of Psychological Sciences, University of Leeds, United Kingdom
5 Department of Obstetrics, Gynaecology and Andrology, Albert Szent-Gyorgy Medical University, Hungary
6 Department of Experimental Medicine, Katholieke Universiteit Leuven, Belgium
7 Department of Medicine, Santiago de Compostela University, Spain
8 Department of Clinical Physiopathology, University of Florence, Italy
9 Reproductive Medicine Centre, Malmo University Hospital, Sweden
10 Department of Endocrinology, Royal Free and University College Hospital Medical School, United Kingdom
11 Department of Reproductive Biology, Imperial College London, United Kingdom
12 Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, Poland
13 Department of Human Nutrition, University of Glasgow, United Kingdom
14 Andrology Unit, United Laboratories of Tartu University Clinics, Estonia
15 Department of Andrology and Endocrinology, Katholieke Universiteit Leuven, Belgium
* To whom correspondence should be addressed. E-mail: david.m.lee@manchester.ac.uk .
Accepted 26 January 2009
Abstract
BACKGROUND Although there is evidence that vitamin D inadequacy may be linked to adverse cognitive outcomes, results have been inconsistent. The aim of our study was to examine the association between 25-hydroxyvitamin D (25(OH)D) levels and cognitive performance in middle-aged and older European men. METHODS This population-based cross-sectional study included 3,369 men aged 40 to 79 years from eight centres enrolled in the European Male Ageing Study (EMAS). Cognitive function was assessed using the Rey-Osterrieth Complex Figure test (ROCF), the Camden Topographical Recognition Memory test (CTRM) and the Digit Symbol Substitution test (DSST). Serum 25(OH)D levels were measured by radioimmunoassay. Additional assessments included physical activity, functional performance and mood/depression. Associations between cognitive function and 25(OH)D were explored using locally weighted and linear regression models. RESULTS 3,133 men, mean (±SD) age 60±11 years were included in the analysis. The mean 25(OH)D concentration was 63±31 nmol/L. In age-adjusted linear regressions higher levels of 25(OH)D were associated with higher scores on the ROCF-copy (
per 10 nmol/L=0.096; 95%CI 0.049-0.144), CTRM (
per 10 nmol/L=0.075; 95%CI 0.026-0.124) and DSST (
per 10 nmol/L=0.318; 95%CI 0.235-0.401) tests. After adjusting for additional confounders, 25(OH)D levels were associated with the DSST test only (
per 10 nmol/L=0.152; 95%CI 0.051-0.253). Locally weighted and spline regressions suggested the relationship between 25(OH)D and cognitive function was most pronounced at 25(OH)D concentrations below 35 nmol/L. CONCLUSION In this study lower 25(OH)D levels were associated with poorer performance on the DSST test. Further research is warranted to determine whether vitamin D sufficiency may play a role in preserving cognitive function in older adults.
Similar entries
- Role of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus
- The Association of Age with Plasma Arginine Vasopressin and Plasma Osmolality
- Evidence for Cardiomyocyte Renewal in Humans
- Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
- C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia
- Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with di
- Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease
- The underdetection of cognitive impairment in nursing homes in the Dublin area. The need for on-going cognitive assessment
- Vascular Factors and Markers of Inflammation in Offspring With a Parental History of Late-Onset Alzheimer Disease
- Ideal Management of Diabetes Mellitus and Dementia





